Cargando…

Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells

Signaling via the B-cell receptor (BCR) is a key driver and therapeutic target in chronic lymphocytic leukemia (CLL). BCR stimulation of CLL cells induces expression of eIF4A, an initiation factor important for translation of multiple oncoproteins, and reduces expression of PDCD4, a natural inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilmore, Sarah, Rogers-Broadway, Karly-Rai, Taylor, Joe, Lemm, Elizabeth, Fell, Rachel, Stevenson, Freda K., Forconi, Francesco, Steele, Andrew J., Coldwell, Mark, Packham, Graham, Yeomans, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429177/ https://www.ncbi.nlm.nih.gov/pubmed/34398253 http://dx.doi.org/10.1007/s00018-021-03910-x

Ejemplares similares

B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells
por: Taylor, Joe, et al.
Publicado: (2022)

PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells
por: Yeomans, Alison, et al.
Publicado: (2016)

Network analysis reveals a major role for 14q32 cluster miRNAs in determining transcriptional differences between IGHV-mutated and unmutated CLL
por: Bryant, Dean, et al.
Publicado: (2023)

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia
por: Smith, Lindsay D., et al.
Publicado: (2019)

Amplification efficiency and thermal stability of qPCR instrumentation: Current landscape and future perspectives
por: ROGERS-BROADWAY, KARLY-RAI, et al.
Publicado: (2015)

B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells
por: Minton, Annabel R., et al.
Publicado: (2022)

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity
por: Valle-Argos, Beatriz, et al.
Publicado: (2021)

Elucidating the role of DEPTOR in Alzheimer’s disease
por: DAVIES, JULIE, et al.
Publicado: (2014)

Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro
por: ROGERS-BROADWAY, KARLY-RAI, et al.
Publicado: (2016)

Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms
por: Taylor, Joe, et al.
Publicado: (2020)

Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
por: De Falco, Filomena, et al.
Publicado: (2015)

Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis
por: Grabow, S, et al.
Publicado: (2016)

miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis
por: Liu, Yanhui, et al.
Publicado: (2019)

eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis
por: Ruan, Hang, et al.
Publicado: (2020)

S141: INHIBITION OF MYC TRANSLATION THROUGH TARGETING OF THE NEWLY IDENTIFIED PHB-EIF4F COMPLEX AS THERAPEUTIC STRATEGY INCHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
por: Largeot, Anne, et al.
Publicado: (2023)

Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer
por: Matsumoto, Masaru, et al.
Publicado: (2015)

Metformin blocks MYC protein synthesis in colorectal cancer via mTOR‐4EBP‐eIF4E and MNK1‐eIF4G‐eIF4E signaling
por: Shen, Peng, et al.
Publicado: (2018)

Mcl-1 and tumor cell persistence
por: Pfannenstiel, Lukas W., et al.
Publicado: (2014)

High-grade B-Cell lymphoma with MYC and BCL6 rearrangements associated with Richter transformation of chronic lymphocytic leukemia
por: Rogers, Thomas S, et al.
Publicado: (2019)

Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation
por: Coni, Sonia, et al.
Publicado: (2020)

Cytokine-dependent and cytokine-independent roles for Mcl-1: genetic evidence for multiple mechanisms by which Mcl-1 promotes survival in primary T lymphocytes
por: Dunkle, A, et al.
Publicado: (2011)

Pharmacological targeting of eIF4E in primary CLL lymphocytes
por: Martinez-Marignac, V, et al.
Publicado: (2013)

An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia
por: Broadway-Duren, Jackie
Publicado: (2022)

c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1
por: Campone, Mario, et al.
Publicado: (2011)

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
por: Gregory, G P, et al.
Publicado: (2015)

A MYC/GCN2/eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer
por: Schmidt, Stefanie, et al.
Publicado: (2019)

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
por: Kelly, Gemma L., et al.
Publicado: (2014)

Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1
por: Zhao, Yang, et al.
Publicado: (2020)

SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia
por: Paiva, Cody, et al.
Publicado: (2017)

Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1
por: Fiorcari, Stefania, et al.
Publicado: (2022)

Mcl-1 protects prostate cancer cells from cell death mediated by chemotherapy-induced DNA damage
por: Reiner, Teresita, et al.
Publicado: (2015)

Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice
por: Anstee, Natasha S, et al.
Publicado: (2017)

The Initiation Factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G Are Not Involved in Translation Driven by Hepatitis C Virus IRES in Human Cells
por: González-Almela, Esther, et al.
Publicado: (2018)

Engineered transient and stable overexpression of translation factors eIF3i and eIF3c in CHOK1 and HEK293 cells gives enhanced cell growth associated with increased c-Myc expression and increased recombinant protein synthesis
por: Roobol, Anne, et al.
Publicado: (2020)

Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer
por: Savinainen, K J, et al.
Publicado: (2004)

Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
por: Nardi, Francesca, et al.
Publicado: (2023)

Purported Mcl-1 inhibitor marinopyrrole A fails to show selective cytotoxicity for Mcl-1-dependent cell lines
por: Eichhorn, J M, et al.
Publicado: (2013)

The multiple mechanisms of MCL1 in the regulation of cell fate
por: Widden, Hayley, et al.
Publicado: (2021)

Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling
por: Zhao, Yuchong, et al.
Publicado: (2021)

Regulation of Mcl-1 Expression in Context to Bone Marrow Stromal Microenvironment in Chronic Lymphocytic Leukemia()
por: Balakrishnan, Kumudha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ao5p6osrcrtmegvj1n72n1fjk7